SlideShare a Scribd company logo
1 of 16
Scientific  Supervisors : Prof. Dr.B.I.Polyakov Dr.M.Y. Fedyanin Presented by: Dr.Ye Hlaing Bwar Significance of Prognostic Factors in Epithelial Ovarian Cancer M.V.LOMONOSOV MOSCOW STATE UNIVERSITY Faculty of Basic Medicine
Ovarian cancer is the fifth leading cause of death from cancer in women. Leading cause of death from gynecological cancer   in United State .
Mortality  from Ovarian Cancer ,[object Object],[object Object],[object Object],[object Object]
Prognostic factor  -  any measurement  available at the time of surgery or diagnosis  that correlates with disease-free or overall  survival  and, as a result, is able to correlate  with the natural history of the disease.  (>90%) Epithelial Ovarian Cancer
Prognostic Factors in Epithelial Ovarian Cancer Prognostic Factors -  Age -  Histology -  Grade -  Stage(FIGO)  -  ECOG performance status  -  CA125 -  Ascites -  Residual disease -  Ploidy -  Type of chemotherapy - Interval debulking
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Diagnosis
Aim of Study To indentify the statistical significance prognostic factors in epithelial ovarian cancer treated with surgery and primary systemic chemotherapy.
[object Object],[object Object],[object Object],[object Object],Objectives of study
Patients and Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Patients and Methods Statistical Analysis -  MedCalc software (version 9.6) -  x 2  test to compare distribution of baseline characteristics -  Fisher’s exact test where appropriate -  Kaplan-Meier method for survivals, log-rank test for comparison & Cox  proportional hazard regression models for multivariate analysis Follow-up  -  every 3 months for 1 st  two years, every 6 months for next 3 yrs &  annually thereafter
Distribution of Patients Baseline Characteristics (n=55)
5 year Overall Survival Rate (n=55)
Univariate Analysis of Prognostic Factors
Significance in  Sub-group of prognostic factor
CONCLUSION 1.  Statistical Significance of Prognostic Factors Age  (P=0.028). Histology  (P=0.035). FIGO stage  (P=0.022). Ascites  (P=0.028). ,[object Object],[object Object],[object Object],2. ,[object Object],[object Object],[object Object],[object Object],3.
Thank You!

More Related Content

What's hot

Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...
Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...
Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...CSCJournals
 
Pelvic insufficiency fracture
Pelvic insufficiency fracturePelvic insufficiency fracture
Pelvic insufficiency fractureKanhu Charan
 
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...Apollo Hospitals
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...European School of Oncology
 
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...Hugo Raul Castro Salguero
 
Dr naseer baloch journal club
Dr naseer baloch journal clubDr naseer baloch journal club
Dr naseer baloch journal clubDrHafeez Yaqoob
 
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...Health Sciences North | Horizon Santé Nord
 
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
632   0713 - ferreyro bl - predictive score for estimating cancer after venou...632   0713 - ferreyro bl - predictive score for estimating cancer after venou...
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...Debourdeau Phil
 
Innovations in Pancreatic Cancer: A Reason to Hope
Innovations in Pancreatic Cancer: A Reason to HopeInnovations in Pancreatic Cancer: A Reason to Hope
Innovations in Pancreatic Cancer: A Reason to HopeChristopher Kanski
 
2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot
2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot
2014 Ovarian Cancer National Conference: Launching the Women's Cancer MoonshotOvarian Cancer Research Fund Alliance
 
Management of Early Breast Cancer
Management of Early Breast CancerManagement of Early Breast Cancer
Management of Early Breast CancerPhilip Mensah
 
Pancreatic cancer (6 October 2014)
Pancreatic cancer (6 October 2014)Pancreatic cancer (6 October 2014)
Pancreatic cancer (6 October 2014)Zeena Nackerdien
 
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...iosrjce
 
Bevacizumab plus m folfox6 versus mfolfox6 alone as first line
Bevacizumab plus m folfox6 versus mfolfox6 alone as first lineBevacizumab plus m folfox6 versus mfolfox6 alone as first line
Bevacizumab plus m folfox6 versus mfolfox6 alone as first lineKishore Chandra Korada
 

What's hot (19)

Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...
Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...
Toward Integrated Clinical and Gene Expression Profiles for Breast Cancer Pro...
 
Pelvic insufficiency fracture
Pelvic insufficiency fracturePelvic insufficiency fracture
Pelvic insufficiency fracture
 
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...
Anaesthesia considerations and Implications during Oncologic and Non-Oncologi...
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
 
Dr. Lucas Minig
Dr. Lucas MinigDr. Lucas Minig
Dr. Lucas Minig
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
 
International Journal of Hepatology & Gastroenterology
International Journal of Hepatology & GastroenterologyInternational Journal of Hepatology & Gastroenterology
International Journal of Hepatology & Gastroenterology
 
Dr naseer baloch journal club
Dr naseer baloch journal clubDr naseer baloch journal club
Dr naseer baloch journal club
 
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
State of the Art Radiotherapy in the Treatment of Colorectal Cancer: What Exa...
 
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
632   0713 - ferreyro bl - predictive score for estimating cancer after venou...632   0713 - ferreyro bl - predictive score for estimating cancer after venou...
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
 
Innovations in Pancreatic Cancer: A Reason to Hope
Innovations in Pancreatic Cancer: A Reason to HopeInnovations in Pancreatic Cancer: A Reason to Hope
Innovations in Pancreatic Cancer: A Reason to Hope
 
IJET-V3I2P22
IJET-V3I2P22IJET-V3I2P22
IJET-V3I2P22
 
2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot
2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot
2014 Ovarian Cancer National Conference: Launching the Women's Cancer Moonshot
 
Management of Early Breast Cancer
Management of Early Breast CancerManagement of Early Breast Cancer
Management of Early Breast Cancer
 
Pancreatic cancer (6 October 2014)
Pancreatic cancer (6 October 2014)Pancreatic cancer (6 October 2014)
Pancreatic cancer (6 October 2014)
 
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...
Incidence and Management of Ovarian Cancer Cases in a Tertiary Hospital- A 10...
 
Cancer de la región anal 2019
Cancer de la región anal 2019Cancer de la región anal 2019
Cancer de la región anal 2019
 
Bevacizumab plus m folfox6 versus mfolfox6 alone as first line
Bevacizumab plus m folfox6 versus mfolfox6 alone as first lineBevacizumab plus m folfox6 versus mfolfox6 alone as first line
Bevacizumab plus m folfox6 versus mfolfox6 alone as first line
 

Similar to Yehlaingbwar

Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxOriginal StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxvannagoforth
 
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...iosrjce
 
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCER
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCERROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCER
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCERKanhu Charan
 
Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1guest108e832
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...semualkaira
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...semualkaira
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...semualkaira
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...eshaasini
 
ca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.pptca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.pptMusaibMushtaq
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screeningdaranisaha
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screeningsemualkaira
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screeningsemualkaira
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningJohnJulie1
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningAnonIshanvi
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningEditorSara
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningNainaAnon
 
Prostate cancer 2018: A brief overview
Prostate cancer 2018: A brief overviewProstate cancer 2018: A brief overview
Prostate cancer 2018: A brief overviewZeena Nackerdien
 
Evolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screeningEvolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screeningsummer elmorshidy
 
A retrospective study on ovarian cancer with a median follow-up of 36 months ...
A retrospective study on ovarian cancer with a median follow-up of 36 months ...A retrospective study on ovarian cancer with a median follow-up of 36 months ...
A retrospective study on ovarian cancer with a median follow-up of 36 months ...AI Publications
 

Similar to Yehlaingbwar (20)

Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxOriginal StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
 
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...
Gemcitabine and Cisplatin In Metastatic Carcinoma Gallbladder. A Single Insti...
 
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCER
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCERROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCER
ROLE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED BREAST CANCER
 
Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
 
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...
 
ca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.pptca prostate by Dr. Musaib Mushtaq.ppt
ca prostate by Dr. Musaib Mushtaq.ppt
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Prostate cancer 2018: A brief overview
Prostate cancer 2018: A brief overviewProstate cancer 2018: A brief overview
Prostate cancer 2018: A brief overview
 
Evolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screeningEvolving recommendations in prostate cancer screening
Evolving recommendations in prostate cancer screening
 
The Continuous Update Project | Prof. Martin Wiseman
The Continuous Update Project | Prof. Martin WisemanThe Continuous Update Project | Prof. Martin Wiseman
The Continuous Update Project | Prof. Martin Wiseman
 
A retrospective study on ovarian cancer with a median follow-up of 36 months ...
A retrospective study on ovarian cancer with a median follow-up of 36 months ...A retrospective study on ovarian cancer with a median follow-up of 36 months ...
A retrospective study on ovarian cancer with a median follow-up of 36 months ...
 

Recently uploaded

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 

Recently uploaded (20)

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 

Yehlaingbwar

  • 1. Scientific Supervisors : Prof. Dr.B.I.Polyakov Dr.M.Y. Fedyanin Presented by: Dr.Ye Hlaing Bwar Significance of Prognostic Factors in Epithelial Ovarian Cancer M.V.LOMONOSOV MOSCOW STATE UNIVERSITY Faculty of Basic Medicine
  • 2. Ovarian cancer is the fifth leading cause of death from cancer in women. Leading cause of death from gynecological cancer in United State .
  • 3.
  • 4. Prognostic factor - any measurement available at the time of surgery or diagnosis that correlates with disease-free or overall survival and, as a result, is able to correlate with the natural history of the disease. (>90%) Epithelial Ovarian Cancer
  • 5. Prognostic Factors in Epithelial Ovarian Cancer Prognostic Factors - Age - Histology - Grade - Stage(FIGO) - ECOG performance status - CA125 - Ascites - Residual disease - Ploidy - Type of chemotherapy - Interval debulking
  • 6.
  • 7. Aim of Study To indentify the statistical significance prognostic factors in epithelial ovarian cancer treated with surgery and primary systemic chemotherapy.
  • 8.
  • 9.
  • 10. Patients and Methods Statistical Analysis - MedCalc software (version 9.6) - x 2 test to compare distribution of baseline characteristics - Fisher’s exact test where appropriate - Kaplan-Meier method for survivals, log-rank test for comparison & Cox proportional hazard regression models for multivariate analysis Follow-up - every 3 months for 1 st two years, every 6 months for next 3 yrs & annually thereafter
  • 11. Distribution of Patients Baseline Characteristics (n=55)
  • 12. 5 year Overall Survival Rate (n=55)
  • 13. Univariate Analysis of Prognostic Factors
  • 14. Significance in Sub-group of prognostic factor
  • 15.